Our way in which we are foreseeing volatility of a fund is to use all available market data together with fund specific technical indicators that cannot be diversified away. We have found twenty-one technical indicators for CC JP which you can use to evaluate future volatility of the entity. Please confirm CC JP INGR JPY AC to double-check if risk estimate we provide are consistent with the epected return of 0.0%.
|Horizon||30 Days Login to change|
CC JP INGR Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
CC JP Projected Return Density Against MarketAssuming 30 trading days horizon, CC JP has beta of 0.0 . This suggests the returns on DOW and CC JP do not appear to be sensitive. Furthermore, It does not look like the company alpha can have any bearing on the equity current valuation.
|Alpha over DOW||=||0.00|
|Beta against DOW||=||0.00|
CC JP Return Volatilitythe fund accepts 0.0% volatility on return distribution over the 30 days horizon. the entity inherits 0.5831% risk (volatility on return distribution) over the 30 days horizon.
CC JP Investment Opportunity
DOW has a standard deviation of returns of 0.58 and is 9.223372036854776E16 times more volatile than CC JP INGR JPY AC. 0% of all equities and portfolios are less risky than CC JP. Compared to the overall equity markets, volatility of historical daily returns of CC JP INGR JPY AC is lower than 0 (%) of all global equities and portfolios over the last 30 days.
CC JP Current Risk Indicators
CC JP Suggested Diversification Pairs
|VMware vs. CC JP|
|Sprint vs. CC JP|
|AGM Group vs. CC JP|
|Leap Therapeutics vs. CC JP|
|Citigroup vs. CC JP|
|Alphabet vs. CC JP|
|Stoneco Ltd vs. CC JP|
|Ford Motor vs. CC JP|
|Visa vs. CC JP|
|Genocea Biosciences vs. CC JP|